Mark Clein

Mark P.
Clein was the founder of United BioSource LLC, founded in 2003, where the title held was President from 2011 to 2012.
Mr. Clein is the founder of Precision For Medicine, Inc., founded in 2012.
Mr. Clein is the founder of Precision AQ, founded in 2012, holding the title of Executive Chairman since 2012.
Mr. Clein is the founder of Precision Medicine Group LLC, founded in 2012, holding the title of Executive Chairman since 2024.
Current jobs include Director at MetaWorks, Inc.; President & Director at PRECISIONeffect, Inc.; Co-Managing Director at Precision For Medicine GmbH; Director at Precision Medicine Group Holdings, Inc.; Director at Precision for Medicine & Oncology (UK) Ltd.; Director at Precision for Medicine & Oncology Holdings (UK) Ltd. since 2017; and Director at Precision Effect Europe Ltd. since 2018.
Former jobs include Chief Executive Officer & Director at Psychiatric Solutions, Inc. from 1999 to 2002; Chief Executive Officer at PMR Corp.
from 1999 to 2002; Managing Director at Rodman & Renshaw, Inc. in 1995; Managing Director-Health Care Investment Banking at Jefferies LLC in 1999; Managing Director at Mabon Securities Corp.
in 1995; Vice President at Sprout Group in 1993; Chief Financial Officer & Executive Vice President at US Bioservices Corp.
from 2002 to 2003; Vice President & Partner at Merrill Lynch Venture Capital, Inc. in 1991 and from 1982 to 1990; Partner at LCI Partners in 2003.
Education includes an MBA from The Trustees of Columbia University in The City of New York and undergraduate studies at The University of North Carolina at Charlotte.